Eagle Pharmaceuticals (NQ: EGRX )

50.67 USD -0.06 (-0.12%)

Official Closing Price Updated: 4:01 PM EST, Jan 15, 2021 Add to My Watchlist

Price and Volume

Volume	78,198
Open	50.23
Bid (Size)	50.67 (4)
Ask (Size)	50.84 (4)
Prev. Close	50.73
Today's Range	49.62 - 51.60
52wk Range	33.80 - 59.98
Shares Outstanding	14,835,438
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Eagle Pharmaceuticals Announces Update in Vasopressin Trial; Trial Date Postponed from January 11, 2021 to February 1, 2021 to Protect Against COVID-19 Concerns

January 11, 2021

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that, on January 8, 2021, the United States District Court for the District of Delaware postponed the January 11,...

Eagle Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference

January 04, 2021

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will present at the 39th...

Performance

YTD	+4.13%	+4.13%
1 Month	+7.76%	+7.76%
3 Month	+9.63%	+9.63%
6 Month	-1.19%	-1.19%
1 Year	-13.03%	-13.03%

More News

Eagle Pharmaceuticals’ Presentation at Piper Sandler 32nd Annual Virtual Healthcare Conference Available for Viewing

November 23, 2020

WaterMill Asset Management Sends Letter to Ziopharm Oncology Shareholders

November 05, 2020

Eagle Pharmaceuticals Reports Third Quarter 2020 Results

November 02, 2020

Eagle Pharmaceuticals Strengthens Management Team to Prepare for Future Growth

November 02, 2020

Eagle Pharmaceuticals to Discuss Third Quarter 2020 Financial Results on November 2, 2020

October 26, 2020

Eagle Pharmaceuticals Commences $25 Million Accelerated Share Repurchase as Part of Existing $160 Million Share Repurchase Program

September 24, 2020

Eagle Pharmaceuticals’ Japanese Licensing Partner, SymBio, Receives Approval of TREAKISYM Ready-To-Dilute (“RTD”) Formulation, with Launch Expected in January 2021

September 23, 2020

Eagle Pharmaceuticals to Present at Upcoming September 2020 Healthcare Conferences

September 08, 2020

EGRX Makes Notable Cross Below Critical Moving Average

November 20, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Search form

The Borger News-Herald

Eagle Pharmaceuticals (NQ: EGRX )

Price and Volume

Top News

Performance

More News